Age dependent effects of NELL-1 isoforms on bone marrow stromal cells

被引:6
作者
Meyers, Carolyn A. [1 ]
Sun, Zhibo [1 ]
Chang, Leslie [1 ]
Ding, Catherine [2 ]
Lu, Amy [1 ]
Ting, Kang [2 ]
Pang, Shen [3 ,4 ,5 ]
James, Aaron W. [1 ,3 ,4 ,5 ]
机构
[1] Johns Hopkins Univ, Dept Pathol, Ross Res Bldg,Room 524A,720 Rutland Ave, Baltimore, MD 21205 USA
[2] Univ Calif Los Angeles, Sch Dent, Div Growth & Dev, Los Angeles, CA 90024 USA
[3] UCLA, Los Angeles, CA 90095 USA
[4] Orthoped Hosp, Dept Orthopaed Surg, Los Angeles, CA 90095 USA
[5] Orthoped Hosp, Res Ctr, Los Angeles, CA 90095 USA
关键词
Mesenchymal stem cell; Nell-1; BMSC; Osteogenesis; PERIVASCULAR STEM-CELLS; DIFFERENTIATION; EXPRESSION; PROLIFERATION; OSTEOGENESIS; ADHESION; DELIVERY; RUNX2; GENE; MICE;
D O I
10.1016/j.jor.2019.02.006
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective: NELL-1 is an osteogenic protein first discovered to control ossification of the cranium. NELL-1 exists in at least two isoforms. The full-length NELL-1 contains 810 amino acid (aa) (NELL-1810), the N-terminal-truncated NELL-1 isoform contains 570 aa (NELL-1570). The differences in cellular effects between NELL-1 isoforms are not well understood. Methods: Here, BMSC were derived from adult or aged mice, followed by overexpression of NELL-1810 or NELL-1570. Cell morphology, proliferation, and gene expression were examined. Results/Conclusions: Overall, the proliferative effect of NELL-1570 was age dependent, showing prominent induction in adult but not aged mice.
引用
收藏
页码:175 / 178
页数:4
相关论文
共 27 条
[1]  
Askarinam A, 2013, TISSUE ENG PT A, V19, P1386, DOI [10.1089/ten.tea.2012.0367, 10.1089/ten.TEA.2012.0367]
[2]   Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation [J].
Bokui, Nobuyuki ;
Otani, Takayuki ;
Igarashi, Koichi ;
Kaku, Junichiro ;
Oda, Mitsuo ;
Nagaoka, Tadahiro ;
Seno, Masaharu ;
Taternatsu, Kenji ;
Okajima, Toshihide ;
Matsuzaki, Takashi ;
Ting, Kang ;
Tanizawa, Katsuyuki ;
Kuroda, Shunichi .
FEBS LETTERS, 2008, 582 (02) :365-371
[3]   NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation [J].
Chen, Feng ;
Walder, Ben ;
James, Aaron W. ;
Soofer, Donnalisa E. ;
Soo, Chia ;
Ting, Kang ;
Zhang, Xinli .
INTERNATIONAL ORTHOPAEDICS, 2012, 36 (10) :2181-2187
[4]   Nfatc2 Is a Primary Response Gene of Nell-1 Regulating Chondrogenesis in ATDC5 Cells [J].
Chen, Weiwei ;
Zhang, Xinli ;
Siu, Ronald K. ;
Chen, Feng ;
Shen, Jia ;
Zara, Janette N. ;
Culiat, Cymbeline T. ;
Tetradis, Sotirios ;
Ting, Kang ;
Soo, Chia .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (06) :1230-1241
[5]   NELL-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2 [J].
Cowan, Catherine M. ;
Zhang, Xinli ;
James, Aaron W. ;
Kim, T. Mari ;
Sun, Nichole ;
Wu, Benjamin ;
Ting, Kang ;
Soo, Chia .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (03) :351-357
[6]   Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects [J].
Desai, J ;
Shannon, ME ;
Johnson, MD ;
Ruff, DW ;
Hughes, LA ;
Kerley, MK ;
Carpenter, DA ;
Johnson, DK ;
Rinchik, EM ;
Culiat, CT .
HUMAN MOLECULAR GENETICS, 2006, 15 (08) :1329-1341
[7]   The C-terminal region of NELL1 mediates osteoblastic cell adhesion through integrin α3β1 [J].
Hasebe, Ai ;
Nakamura, Yoko ;
Tashima, Hiroki ;
Takahashi, Kaneyoshi ;
Iijima, Masumi ;
Yoshimoto, Nobuo ;
Ting, Kang ;
Kuroda, Shun'ichi ;
Niimi, Tomoaki .
FEBS LETTERS, 2012, 586 (16) :2500-2506
[8]   NELL-1 in the treatment of osteoporotic bone loss [J].
James, Aaron W. ;
Shen, Jia ;
Zhang, Xinli ;
Asatrian, Greg ;
Goyal, Raghav ;
Kwak, Jin H. ;
Jiang, Lin ;
Bengs, Benjamin ;
Culiat, Cymbeline T. ;
Turner, A. Simon ;
Seim, Howard B., III ;
Wu, Benjamin M. ;
Lyons, Karen ;
Adams, John S. ;
Ting, Kang ;
Soo, Chia .
NATURE COMMUNICATIONS, 2015, 6
[9]  
James AW, 2017, JCI INSIGHT, P2
[10]   Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma [J].
Jin, Z. ;
Mori, Y. ;
Yang, J. ;
Sato, F. ;
Ito, T. ;
Cheng, Y. ;
Paun, B. ;
Hamilton, J. P. ;
Kan, T. ;
Olaru, A. ;
David, S. ;
Agarwal, R. ;
Abraham, J. M. ;
Beer, D. ;
Montgomery, E. ;
Meltzer, S. J. .
ONCOGENE, 2007, 26 (43) :6332-6340